Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Thermo Fisher Scientific Inc. (TMO) had Revenue of $44.56B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$44.56B
Net Income	$6.70B
Cost of Goods Sold	$26.32B
Gross Profit	$18.24B
Operating Expenses	$36.81B
Operating Income	$7.75B
Non-Operating Income/Expense	$-438.00M
Pre-Tax Income	$7.31B
Normalized Pre-Tax Income	$7.31B
Income after Taxes	$6.76B
Income from Continuous Operations	$6.72B
Consolidated Net Income/Loss	$6.72B
Normalized Income after Taxes	$6.76B
EBIT	$7.75B
EBITDA	$10.53B
Weighted-Average Shares Outstanding (Basic)	377.00M
Weighted-Average Shares Outstanding (Diluted)	378.00M
Earnings per Share (EPS) (Basic)	$17.77
Earnings per Share (EPS) (Diluted)	$17.74
Balance Sheet Financials
Current Assets	$28.71B
Property, Plant, and Equipment	$10.56B
Long-Term Assets	$81.64B
Total Assets	$110.34B
Current Liabilities	$15.19B
Long-Term Debt	$35.85B
Long-Term Liabilities	$41.74B
Total Liabilities	$56.93B
Common Equity	$53.41B
Tangible Shareholders Equity	$-11.79B
Shareholders Equity	$53.41B
Common Shares Outstanding	376.22M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$7.82B
Cash Flow from Investing Activities	$-4.05B
Cash Flow from Financial Activities	$1.80B
Beginning Cash	$4.04B
End Cash	$9.88B
Increase/Decrease in Cash	$5.84B
Stock-Based Compensation	$310.00M
Common Stock Dividends Paid	$-636.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.89
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.74
Gross Margin	40.93%
Operating Margin	17.39%
EBIT Margin	17.39%
EBITDA Margin	23.63%
Pre-Tax Profit Margin	16.40%
Profit Margin	15.05%
Free Cash Flow	$6.34B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.40
Inventory Turnover	4.85
Receiveable Turnover	5.01
Days Sales in Receivables	72.91
Return on Equity	12.58%
Return on Tangible Equity	-57.02%
Return on Assets	6.09%
Return on Investments	7.53%
Book Value Per Share	$141.98
Free Cash Flow per Share	$16.76
Operating Cash Flow per Share	$20.68

Data from Zacks Investment Research, Inc.